Suven Life Sciences : Outcome of the Board Meeting

CSD/NSE&BSE/BM/2022-23

September 2, 2022

To	To
The General Manager	The Manager
Department of Corporate Services	Listing Department
BSE Limited	National Stock Exchange of India Limited
25th Floor, P. J. Towers,	Exchange Plaza, Bandra Kurla Complex
Dalal Street, Mumbai - 400 001	Bandra (E), Mumbai - 400 051
Scrip Code: 543064	Scrip Symbol: SUVENPHAR
Dear Sir/Madam,
Sub: Outcome of the Board Meeting

With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. September 02, 2022, approved the following matters.

Interim Dividend

1. The Board has declared an Interim Dividend of Rs.1.00 per equity share (100% of face value of Rs.1.00 each) and special dividend of Rs. 5.00 per equity share (500% of face value of Rs.1.00), totaling to Rs. 6.00 per equity share (600% of face value of Rs. 1.00 each) for the financial year 2022-23.
2. The Board has approved the Record Date i.e., September 12, 2022 notified earlier by the Company for the purpose of payment of dividend to the eligible shareholders.
3. The above said dividend will be paid on and from September 20, 2022.

The Board Meeting commenced at 12:30 P.M. and concluded at 1:20 P.M.

This is for your information and record.

Thanking you,

Yours faithfully,

For Suven Pharmaceuticals Limited

K Hanumantha Rao

Company Secretary

Suven Pharmaceuticals Limited

Registered Office: # 8-2-334 I SDE Serene Chambers I 3rd Floor I Road No.5

Avenue 7 I Banjara Hills I Hyderabad - 500034 I Telangana I India I CIN:L24299TG2018PLC128171

Tel: [phone] I Fax: [phone] I Email: [e-mail] I www.suvenpharm.com